FMT
TBPH icon

First Mercantile Trust’s Theravance Biopharma TBPH Stock Holding History

First Mercantile Trust’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,370
Closed -$63K – 882
2021
Q2 		$63K Sell
4,370
-537
-11% -$10.1K 0.01% 772
2021
Q1 		$100K Sell
4,907
-924
-16% -$17.6K 0.01% 683
2020
Q4 		$104K Hold
5,831
– – 0.01% 678
2020
Q3 		$104K Buy
5,831
+1,376
+31% +$25.8K 0.01% 662
2020
Q2 		$94K Buy
+4,455
New +$114K 0.01% 690

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

First Mercantile Trust's TBPH Position: Q3 2021 in Review

First Mercantile Trust sold out of Theravance Biopharma (TBPH) in Q3 2021, closing a stake of 4,370 shares — an estimated $63K sold.

First Mercantile Trust first reported a position in TBPH in Q2 2020 and held it in 5 quarters. The position peaked at $104K in Q4 2020. 119 funds tracked by Wall St. Rank hold TBPH as of Q3 2021.

  • First Mercantile Trust reported no remaining Theravance Biopharma position as of Q3 2021 after selling out during the quarter.
  • First Mercantile Trust sold 4,370 Theravance Biopharma shares in Q3 2021, an estimated $63K.
  • First Mercantile Trust first reported a position in Theravance Biopharma in Q2 2020 and held it in 5 quarters.
  • First Mercantile Trust's Theravance Biopharma position peaked at $104K in Q4 2020.
  • 119 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.